Company Profile
Adlai Nortye Ltd. Stock Price, News & Analysis
- Ticker:
- ANL
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, 阿诺医药 is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
10.60 USD (+1.92%)
Close
Last updated: June 23, 2026 at 00:00
682.62M USD
Market cap
Why the stock is moving
ANL is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
阿诺医药 is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, 阿诺医药 is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
阿诺医药 follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, 阿诺医药 sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Adlai Nortye Reports Full Year 2024 Financial Results and Business Updates
Source: Adlai Nortye Ltd.
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Adlai Nortye Ltd. (ANL)?
Adlai Nortye Ltd. (ANL) most recently closed at 10.60 USD, a +1.92% move versus the previous session.
What is the market cap of Adlai Nortye Ltd. (ANL)?
Adlai Nortye Ltd. currently has a market capitalization of 682.62M USD on BioPharmSignal.
What does Adlai Nortye Ltd. do?
阿诺医药 is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ANL stock listed?
Adlai Nortye Ltd. (ANL) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, 阿诺医药 is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Which conditions is Adlai Nortye Ltd. targeting with Investors?
阿诺医药 is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.